Study to Assess the Performance of MagnEtOs Flex Matrix Compared to Cellular Allograft

NCT06415123 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-08-22

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the performance of MagnetOs Flex Matrix in patients with leg pain and/or back pain.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

MagnetOs Flex Matrix

MagnetOsTM Flex Matrix is a resorbable and osteoconductive bone graft for the repair of bony defects.

Sponsors & Collaborators

  • Research Source

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-11
Primary Completion
2026-05-31
Completion
2027-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06415123 on ClinicalTrials.gov